PMID: 6970727Aug 1, 1980Paper

Establishment and characterization of a human acute monocytic leukemia cell line (THP-1)

International Journal of Cancer. Journal International Du Cancer
S TsuchiyaK Tada

Abstract

A human leukemic cell line (THP-1) cultured from the blood of a boy with acute monocytic leukemia is described. This cell line had Fc and C3b receptors, but no surface or cytoplasmic immunoglobulins. HLA haplotypes of THP-1 were HLA-A2, -A9, -B5, -DRW1 and -DRW2. The monocytic nature of the cell line was characterized by: (1) the presence of alpha-naphthyl butyrate esterase activities which could be inhibited by NaF; (2) lysozyme production; (3) the phagocytosis of latex particles and sensitized sheep erythrocytes; and (4) the ability to restore T-lymphocyte response to Con A. The cells did not possess Epstein-Barr virus-associated nuclear antigen. These results indicate that THP-1 is a leukemia cell line with distinct monocytic markers. During culture, THP-1 maintained these monocytic characteristics for over 14 months.

References

Feb 1, 1979·International Journal of Cancer. Journal International Du Cancer·R HurwitzJ Kersey
May 15, 1976·International Journal of Cancer. Journal International Du Cancer·C Sundström, K Nilsson
Jul 27, 1978·The New England Journal of Medicine·F P SiegalR A Good
May 24, 1979·Nature·H S KorenJ W Larrick
Apr 1, 1977·The Tohoku Journal of Experimental Medicine·H SuzukiT Y Yamamoto
Jul 1, 1972·The Journal of Experimental Medicine·H B Dickler, H G Kunkel
May 1, 1973·International Journal of Cancer. Journal International Du Cancer·B M Reedman, G Klein
Jan 1, 1967·Proceedings of the Society for Experimental Biology and Medicine·Y Hinuma, J T Grace
Dec 1, 1973·The Journal of Clinical Investigation·A EdenV Nussenzweig
Nov 1, 1972·The Journal of Clinical Investigation·D W Golde, M J Cline
Aug 1, 1970·Journal of Cellular Physiology·B L Pike, W A Robinson

❮ Previous
Next ❯

Citations

Feb 5, 2000·Cell Motility and the Cytoskeleton·F RichelmeP Bongrand
Jun 22, 2000·Journal of Cellular Biochemistry·W Zeng, E Remold-O'Donnell
Jul 1, 1994·Journal of Neuroscience Research·K WilliamsJ McLaurin
Jun 1, 1991·Cytotechnology·E AboodT C Pearson
Jan 1, 1993·Cancer Chemotherapy and Pharmacology·S IshiiT Tsuruo
Aug 7, 1999·Clinical Reviews in Allergy & Immunology·T D Bigby
Jul 12, 2008·Cancer Immunology, Immunotherapy : CII·Ryuji KobayashiRalph S Freedman
Feb 21, 2013·Cell and Tissue Research·Mareike Müller, Hans Peter Elsässer
Feb 3, 2009·The Protein Journal·Kenneth VerstraeteSavvas N Savvides
Sep 14, 2006·Pharmaceutical Research·Lipa K Shah, Mansoor M Amiji
Nov 17, 2009·Journal of Thrombosis and Thrombolysis·Stavros ApostolakisDemetrios A Spandidos
Feb 23, 2010·In Vitro Cellular & Developmental Biology. Animal·Racha Helal, Matthias F Melzig
Jun 19, 2010·Journal of Cardiovascular Translational Research·Anupam MittalVeena Dhawan
Aug 10, 2010·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Lucie SedlackovaIlona Hromadnikova
Aug 3, 1993·Biochemical Pharmacology·X CanatP Casellas
Sep 14, 1994·Journal of Immunological Methods·W S Walker
Feb 10, 1994·Journal of Immunological Methods·F Cook, L J Eales
Dec 1, 1995·Journal of Immunological Methods·A R Mire-SluisR Thorpe
Sep 1, 1989·Journal of the Neurological Sciences·H TerunumaY Ohara

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.